Research presented at the ASCO Annual Meeting 2025 highlighted potential new standards of care and other advances in ...

Scientists conducting medical research are facing an existential crisis: Layoffs and budget cuts pushed by President Trump ...

Three of five patients with advanced colorectal cancer responded to leronlimab, including one complete response lasting five years, according to new data.

Appendix cancer is a rare but increasingly recognized malignancy, often discovered incidentally during surgery for presumed ...

Dr. Benjamin Weinberg, Associate Professor at Georgetown University and Principal Investigator of CytoDyn’s colorectal cancer (“CRC”) program, will present the Company’s clinical data at the ESMO ...

Cancer patients receiving immune checkpoint inhibitor (ICI) therapy may experience more severe toxicity and have a greater risk of death if they have recently used proton pump inhibitors (PPIs), ...

A new survey from Takeda due to be presented at the ESMO Gastrointestinal Cancers Congress in Spain this week highlights ...

Find the latest Gastrointestinal Cancer news articles, videos, ... Rectal location and timing of diagnosis had minimal impact on cancer-specific and all-cause mortality rates for patients with ...

BE is the only known precursor to esophageal cancer. The condition is caused by prolonged exposure of the esophagus to ...

Martin, who died this week of colon cancer at the age of 30, said his five-year battle began with a single symptom.

NHS FDP Cancer 360 dominated the headlines last month as Government announced it is to be rolled out across the NHS. Initially piloted at Chelsea and Westminster NHS Foundation Trust’s gynaecology ...